Profile
Full Name
Immunovant, Inc.Ticker Symbol
IMVTExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
June 21, 2019Indexes
Not includedWebsite
http://immunovant.comEmployees
207Key Details
Price
$15.15(+2.09%)
Market cap
$2.57B(Mid cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
-$1.88(-9.94% YoY)
Next earnings date
May 29, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Immunovant doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Mar 20, 25 Guggenheim
BuyMar 20, 25 B of A Securities
BuyMar 19, 25 HC Wainwright & Co.
BuyMar 10, 25 Guggenheim
BuyFeb 10, 25 HC Wainwright & Co.
BuyFeb 10, 25 Guggenheim
BuyFeb 7, 25 HC Wainwright & Co.
BuyJan 15, 25 B of A Securities
BuyJan 3, 25 Wolfe Research
Peer PerformDec 19, 24 Wells Fargo
OverweightInstitutional Ownership
- What is the ticker symbol for Immunovant?
- Does Immunovant pay dividends?
- What sector is Immunovant in?
- What industry is Immunovant in?
- What country is Immunovant based in?
- When did Immunovant go public?
- Is Immunovant in the S&P 500?
- Is Immunovant in the NASDAQ 100?
- Is Immunovant in the Dow Jones?
- When was Immunovant's last earnings report?
- When does Immunovant report earnings?
- Should I buy Immunovant stock now?
What is the ticker symbol for Immunovant?
The ticker symbol for Immunovant is NASDAQ:IMVT
Does Immunovant pay dividends?
No, Immunovant does not pay dividends
What sector is Immunovant in?
Immunovant is in the Healthcare sector
What industry is Immunovant in?
Immunovant is in the Biotechnology industry
What country is Immunovant based in?
Immunovant is headquartered in United States
When did Immunovant go public?
Immunovant's initial public offering (IPO) was on June 21, 2019
Is Immunovant in the S&P 500?
No, Immunovant is not included in the S&P 500 index
Is Immunovant in the NASDAQ 100?
No, Immunovant is not included in the NASDAQ 100 index
Is Immunovant in the Dow Jones?
No, Immunovant is not included in the Dow Jones index
When was Immunovant's last earnings report?
Immunovant's most recent earnings report was on Feb 6, 2025
When does Immunovant report earnings?
The next expected earnings date for Immunovant is May 29, 2025
Should I buy Immunovant stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions